{
    "clinical_study": {
        "@rank": "58860", 
        "acronym": "COBRAPed", 
        "arm_group": [
            {
                "arm_group_label": "Non-severe asthma", 
                "description": "Children Controlled without treatment or with low doses of inhaled corticosteroids (<500 mg / day beclometasone equivalent) asthma\nand Children with normal EFR\nand Children who did not have more severe exacerbation (assessed taking oral corticosteroids) in the previous year\nand Children not admitted in the previous year for asthma"
            }, 
            {
                "arm_group_label": "Severe asthma", 
                "description": "Asthmatic child who, despite treatment with a combination of inhaled corticosteroids (at least 800 mcg / day equivalent Beclomethasone) bronchodilators and long-acting or properly taken daily leukotriene (inhaler technique and compliance verified) presents one of the 3 criteria following:\nPersistence of symptoms or chronic use of bronchodilators short duration of action at least three times a week for at least 3 months\nexacerbations in the previous year:\nat least one care unit admission or continued resuscitation\nat least two hospitalizations for acute severe asthma requiring IV therapy\nat least 2 courses of oral corticosteroids for exacerbations\npost BD FEV <80% or UARS post BD> 150% predicted"
            }
        ], 
        "biospec_descr": {
            "textblock": "-  whole blood\n\n        -  serum\n\n        -  Bronchoalveolar lavage fluid\n\n        -  bronchial brushing and washing specimens"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this prospective study is:\n\n        -  to identify by cluster analysis the main phenotypes of severe asthma and factors\n           involved in the severity,\n\n        -  to determine the clinical and functional outcomes,\n\n        -  to identify the factors associated with severe asthma from childhood  to adulthood."
        }, 
        "brief_title": "Cohort Analysis of Clinical and Biological Severe Childhood Asthma", 
        "completion_date": {
            "#text": "September 2031", 
            "@type": "Anticipated"
        }, 
        "condition": "Severe Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "detailed_description": {
            "textblock": "Severe asthma involves about 5 % of asthmatic children and is associated with a high impact\n      on hospitalizations, absenteeism and quality of life.\n\n      Although our knowledge has progressed in a substantial way during the last ten years, a\n      number of unresolved questions persist in particular as regard to the contributing factors\n      and outcomes from early childhood to adulthood.\n\n      After parental agreement the following elements will be collected at inclusion: clinical\n      environmental data, pulmonary function, allergy test data (skin prick tests and specific\n      IgE), blood and serum samples for biobank (DNA / SERUM).  In a restricted number of children\n      a more extensive work up will be performed which may include flexible bronchoscopy,\n      bronchial brushing and bronchoalveolar lavage.\n\n      The follow-up will be performed every 6 months within the framework of the usual care\n      including collection of clinical data and pulmonary function tests. The allergic status will\n      be done again at 6-7 years, 12 years and 18 years.\n\n      In the group of children having non-severe asthma, the follow-up will be annual with\n      collection of clinical data and pulmonary function tests."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Children with severe asthma:\n\n          -  Children aged 3 to 12 years\n\n          -  Asthmatic child who, despite treatment with a combination of inhaled corticosteroids\n             (at least 800 mcg / day equivalent Beclomethasone) bronchodilators and long-acting or\n             properly taken daily leukotriene (inhaler technique and compliance verified) presents\n             one of the criteria following:\n\n          -  Persistence of symptoms or chronic use of bronchodilators short duration of action at\n             least three times a week for at least 3 months\n\n          -  exacerbations in the previous year:\n\n               -  at least one care unit admission or continued resuscitation\n\n               -  at least two hospitalizations for acute severe asthma requiring IV therapy\n\n               -  at least 2 courses of oral corticosteroids for exacerbations\n\n          -  post BD FEV <80% or UARS post BD> 150% predicted\n\n          -  Signature of consent or the holder (s) of parental authority\n\n        Patients with non-severe asthma:\n\n        Inclusion Criteria\n\n          -  Children aged 3 to 12 years\n\n          -  Controlled without treatment or with low doses of inhaled corticosteroids (<500 mg /\n             day beclometasone equivalent) asthma\n\n          -  Children with normal EFR\n\n          -  Children who did not have more severe exacerbation (assessed taking oral\n             corticosteroids) in the previous year\n\n          -  Children not admitted in the previous year for asthma.\n\n          -  Signature of consent or the holder (s) of parental authority\n\n        Exclusion Criteria:\n\n          -  Children with bronchopulmonary dysplasia\n\n          -  Children with severe sequelae of viral infections\n\n          -  Refusal of the child or parents"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "3 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Primary Care Clinic"
            }
        }, 
        "enrollment": {
            "#text": "676", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02114034", 
            "org_study_id": "NI12004", 
            "secondary_id": "N\u00b0 ID RCB: 2012-A00539-34"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Severe asthma,", 
            "child,", 
            "outcome,"
        ], 
        "lastchanged_date": "April 14, 2014", 
        "location": {
            "contact": {
                "email": "j.deblic@nck.aphp.fr", 
                "last_name": "Jacques DE BLIC, PUPH", 
                "phone": "00 33 1 44 49 48 46"
            }, 
            "contact_backup": {
                "email": "laurence.lecomte@nck.aphp.fr", 
                "last_name": "Laurence Lecomte, PhD", 
                "phone": "+33 1 71 19 64 94"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75015"
                }, 
                "name": "Service de Pneumologie et allergologie p\u00e9diatrique, H\u00f4pital Necker-Enfants Malades"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "2", 
        "official_title": "Cohort Analysis of Clinical and Biological Severe Childhood Asthma", 
        "overall_contact": {
            "email": "j.deblic@nck.aphp.fr", 
            "last_name": "Jacques DE BLIC, PUPH", 
            "phone": "00 33 1 44 49 48 46"
        }, 
        "overall_contact_backup": {
            "email": "laurence.lecomte@nck.aphp.fr", 
            "last_name": "Laurence Lecomte, PhD", 
            "phone": "+33 1 71 19 64 94"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2031", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A prospective follow-up of a cohort of severe pediatric asthma. To improve the identification of risk factors for severe asthma, a group of children with non-severe asthma will also be included", 
            "measure": "The identification of risk factors for severe asthma", 
            "safety_issue": "No", 
            "time_frame": "18 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02114034"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Identify the functional and clinical outcome in a longitudinal follow-up to a link with asthma in adults.\nIdentify the factors involved appearing during growth or adulthood (pediatric factors associated with severe asthma profile adult).", 
                "measure": "In the medium and longer term assessment", 
                "safety_issue": "No", 
                "time_frame": "4 years"
            }, 
            {
                "description": "Identify the main phenotypes of severe asthma by the cluster analysis\nIdentify the factors involved in severity during childhood", 
                "measure": "A short-term assessment", 
                "safety_issue": "No", 
                "time_frame": "4 years"
            }, 
            {
                "measure": "Establish a collection of biological samples (serum bank, DNA Bank, tissue Bank) to search for biomarkers of severity and genetic risk factors for the development of asthma in children.", 
                "safety_issue": "No", 
                "time_frame": "18 years"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}